AI assistant
Sending…
InspireMD, Inc. — Director's Dealing 2025
Aug 1, 2025
34187_dirs_2025-08-01_25523148-8394-4e51-8f9d-89dacfcdaad9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: InspireMD, Inc. (NSPR)
CIK: 0001433607
Period of Report: 2025-07-30
Reporting Person: ROUBIN GARY S (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2025-07-30 | Common Stock | P | 41322 | $2.42 | Acquired | 608425 | Direct |
Footnotes
F1: The shares of common stock reported in this row represent shares of restricted stock that were acquired in a private placement transaction on July 30, 2025 pursuant to an exemption from the registration requirements under Section 4(a)(2) of the Securities Act of 1933, as amended (the "Private Placement").
F2: The purchase price per share of common stock in the Private Placement was $2.42.
More from InspireMD, Inc.
Regulatory Filings
2026
May 22
Interim / Quarterly Report
2026
May 7
Annual Report
2026
Apr 20
Regulatory Filings
2026
Apr 3
Regulatory Filings
2026
Apr 3
Annual Report
2026
Mar 18
Major Shareholding Notification
2026
Feb 17
Major Shareholding Notification
2026
Feb 11
Major Shareholding Notification
2026
Feb 2
Director's Dealing
2026
Feb 2